Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05845424
PHASE4

High-intensity Statin and Ezetimibe Therapy for Asymptomatic Patients With Positive Coronary Calcium

Sponsor: Samsung Medical Center

View on ClinicalTrials.gov

Summary

The aim of this study is to compare safety and efficacy between the aggressive treatment with combination of high-intensity statin and ezetimibe and the current standard lipid lowering treatment in asymptomatic patients with presence of coronary calcification.

Official title: Comparison of Efficacy and Safety of High-Intensity Statin and Ezetimibe Combination Versus StanDard carE in AsymptomatiC PatIentS wIth Presence of COroNary Artery CALCIUM (DECISION-CAL)

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

6000

Start Date

2023-07-03

Completion Date

2030-06-30

Last Updated

2025-01-14

Healthy Volunteers

No

Interventions

DRUG

Guideline directed statin therapy

At least moderate intensity statin, recommended by the current guideline based on the ASCVD risk

DRUG

High intensity statin plus ezetimibe therapy

Rosuvastatin 20 mg + Ezetimibe 10 mg

Locations (1)

SamsungMedicalCenter

Seoul, South Korea